Debbie J Mustacich1, Li-Wen Lai2, Michael J Bernas1, Jazmine A Jones1, Reginald J Myles1, Phillip H Kuo3, Walter H Williams3, Charles L Witte1, Robert P Erickson4, Marlys Hearst Witte5. 1. Department of Surgery, University of Arizona College of Medicine, Tucson. 2. Department of Pathology, University of Arizona College of Medicine, Tucson. 3. Medical Imaging (Nuclear Medicine), University of Arizona College of Medicine, Tucson. 4. Department of Pediatrics, University of Arizona College of Medicine, Tucson. Electronic address: erickson@peds.arizona.edu. 5. Department of Surgery, University of Arizona College of Medicine, Tucson; Department of Pediatrics, University of Arizona College of Medicine, Tucson. Electronic address: lymph@surgery.arizona.edu.
Abstract
BACKGROUND: The lymphatic system is essential for maintaining the balance of interstitial fluid in tissues and for returning protein-rich fluids (lymph) to the bloodstream. Congenital lymphatic defects lead to accumulation of lymph in peripheral tissues and body cavities, termed primary lymphedema. To date, only a limited number of individual genes have been identified in association with primary lymphedema. However, variability of age of onset and severity of lymphatic abnormalities within some families suggests that multiple mutations or genes may be responsible, thus hampering efforts to identify individual associated genes. METHODS: Whole exome sequencing (WES) was performed in 4 members of a large multigeneration family with highly variable lymphedema and followed by Sanger sequencing for identified mutations in 34 additional family members. Genotypes were correlated with clinical and lymphangioscintigraphic phenotypes. RESULTS: WES uncovered 2 different mechanotransducer PIEZO1 mutations and one FOXC2 transcription factor mutation in various combinations. Sanger sequencing confirmed the presence/absence of the 3 variants in affected and unaffected family members and co-segregation of one or more variants with disease. Genetic profiles did not clearly correlate with the highly variable severity of lymphatic abnormalities. CONCLUSIONS: WES in lymphedema families can uncover unexpected combinations of several lymphedema-associated mutations. These findings provide essential information for genetic counseling and reveal complex gene interactions in lymphatic developmental pathways. These can offer insights into the complex spectrum of clinical and lymphatic lymphedema phenotypes and potential targets for treatment.
BACKGROUND: The lymphatic system is essential for maintaining the balance of interstitial fluid in tissues and for returning protein-rich fluids (lymph) to the bloodstream. Congenital lymphatic defects lead to accumulation of lymph in peripheral tissues and body cavities, termed primary lymphedema. To date, only a limited number of individual genes have been identified in association with primary lymphedema. However, variability of age of onset and severity of lymphatic abnormalities within some families suggests that multiple mutations or genes may be responsible, thus hampering efforts to identify individual associated genes. METHODS: Whole exome sequencing (WES) was performed in 4 members of a large multigeneration family with highly variable lymphedema and followed by Sanger sequencing for identified mutations in 34 additional family members. Genotypes were correlated with clinical and lymphangioscintigraphic phenotypes. RESULTS: WES uncovered 2 different mechanotransducer PIEZO1 mutations and one FOXC2 transcription factor mutation in various combinations. Sanger sequencing confirmed the presence/absence of the 3 variants in affected and unaffected family members and co-segregation of one or more variants with disease. Genetic profiles did not clearly correlate with the highly variable severity of lymphatic abnormalities. CONCLUSIONS: WES in lymphedema families can uncover unexpected combinations of several lymphedema-associated mutations. These findings provide essential information for genetic counseling and reveal complex gene interactions in lymphatic developmental pathways. These can offer insights into the complex spectrum of clinical and lymphatic lymphedema phenotypes and potential targets for treatment.
Authors: M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: Dongwon Choi; Eunkyung Park; Eunson Jung; Boksik Cha; Somin Lee; James Yu; Paul M Kim; Sunju Lee; Yeo Jin Hong; Chester J Koh; Chang-Won Cho; Yifan Wu; Noo Li Jeon; Alex K Wong; Laura Shin; S Ram Kumar; Ivan Bermejo-Moreno; R Sathish Srinivasan; Il-Taeg Cho; Young-Kwon Hong Journal: JCI Insight Date: 2019-03-07
Authors: Carole Sargent; Julien Bauer; Muhamed Khalil; Parker Filmore; Michael Bernas; Marlys Witte; M Peggy Pearson; Robert P Erickson Journal: Am J Med Genet A Date: 2014-09-22 Impact factor: 2.802
Authors: Sergey G Shcherbak; Anton I Changalidi; Yury A Barbitoff; Anna Yu Anisenkova; Sergei V Mosenko; Zakhar P Asaulenko; Victoria V Tsay; Dmitrii E Polev; Roman S Kalinin; Yuri A Eismont; Andrey S Glotov; Evgeny Y Garbuzov; Alexander N Chernov; Olga A Klitsenko; Mikhail O Ushakov; Anton E Shikov; Stanislav P Urazov; Vladislav S Baranov; Oleg S Glotov Journal: Genes (Basel) Date: 2022-03-17 Impact factor: 4.141